Supplementary Figure S5 from Molecular Characterization of Residual Muscle-Invasive Bladder Cancer Identifies a Scar-Like Transcriptomic Profile with Favorable Prognosis after Neoadjuvant Therapy | Synapse
October 2, 2025Open Access
Supplementary Figure S5 from Molecular Characterization of Residual Muscle-Invasive Bladder Cancer Identifies a Scar-Like Transcriptomic Profile with Favorable Prognosis after Neoadjuvant Therapy
Key Points
A scar-like transcriptomic profile associates with favorable prognosis in bladder cancer post-therapy.
This analysis displays downregulated genes in consensus stroma-rich tumors, revealing key genetic insights.
The research involves differential gene expression analysis comparing specific tumor types to assess outcomes.
These findings may highlight important implications for targeted treatment strategies in bladder cancer cases.
Abstract
Figure S5. Differential gene expression analysis comparing the CC-scar-like to the remaining Consensus stroma-rich tumors. Select downregulated genes have been circled in blue.